JPMorgan Chase & Co. 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-06 10:35 am Sale | 2022-11-30 | 13G | G1 Therapeutics, Inc. GTHX | JPMORGAN CHASE & CO JPM | 2,045,814 4.000% | -94,034 (-4.39%) | Filing |
| 2022-01-21 11:43 am Purchase | 2021-12-31 | 13G | G1 Therapeutics, Inc. GTHX | JPMORGAN CHASE & CO JPM | 2,139,848 5.000% | 2,139,848 (New Position) | Filing |